Company intelligence / Profile preview

Cultivated Biosciences

Horgen/Wädenswil/Saint-Aubin, Zurich, Switzerlandcultivated.bio ↗

Ownership: Private
Employees: ~15
Development stage: Preclinical

Overview

Cultivated Biosciences has developed a patented yeast cream ingredient that mimics the texture and mouthfeel of dairy cream. The product has been validated in applications such as coffee creamers, milk, and ice cream with clients. The company plans to launch commercially in the US in 2025 and Europe in 2026 pending regulatory approval. No clinical results as it’s not a pharma/life science company.

Industry: Non-Drug Biotech

Partnerships

Collaborations with vegan dairy brandsEIT Food Accelerator Network Helsinki program

Beyond the preview

Go deeper on Cultivated Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cultivated Biosciences.

Explore the full profile